Circulating tumor DNA (ctDNA) detection has shown potential in predicting treatment outcomes for patients with colorectal cancer, according to data…
Browsing: Colorectal Cancer
A phase 2/phase 3 clinical trial investigating the efficacy of using circulating tumor DNA (ctDNA) to guide adjuvant chemotherapy in…
The FDA has granted breakthrough device designation to Amadix’s PreveCol, a blood test designed for the early detection of colorectal…
While overall cancer mortality is declining, the rise in colorectal cancer deaths, especially among younger adults, and the increasing incidence…
A recent study published in “Annals of Oncology” by a French research group has made significant strides in precision medicine…
A study co-authored by MIT economist Josh Angrist reveals that colon cancer screenings are significantly more effective than previously thought.…
Key Findings: Personalized Information Impact: Older adults who received personalized information about the benefits and harms of colorectal cancer (CRC)…
A study used a risk-advancement period approach incorporating sex and polygenic risk score (PRS) to determine the appropriate starting ages…
The website of America’s Health Rankings provides comprehensive data on colorectal cancer screening in the United States. As of the…
A study on the cost-effectiveness of liquid biopsy compared to colonoscopy for colorectal cancer (CRC) screening. Here’s a summary of…